Ramucirumab is a cancer medication that interferes with the growth and spread of cancer cells in the body. Ramucirumab is used to treat stomach cancer that has spread to other parts of the body Ramucirumab is usually given after other cancer medicines have been tried without success. Ramucirumab may also be used for purposes not listed in this medication guide.
Cyramza is an FDA approved drug that is prescribed to treat advanced gastric cancer and non-small cell lung cancer. Cyramza is a cancer medication known as a vascular endothelial growth factor or VEGF receptor 2 antagonist. This drug works by blocking the blood supply to tumors in a patient. Cyramza contains a boxed warning regarding the increased risk of hemorrhage that could also lead to severe events. Doctors are advised to stop Cyramza treatment if the patient experiences severe bleeding.